Billiontoone (NASDAQ:BLLN) CTO Sells $2,045,400.00 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) CTO David Tsao sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $102.27, for a total transaction of $2,045,400.00. Following the transaction, the chief technology officer directly owned 1,000 shares in the company, valued at $102,270. The trade was a 95.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Billiontoone Stock Down 1.3%

NASDAQ BLLN traded down $1.32 on Wednesday, reaching $99.38. The stock had a trading volume of 963,691 shares, compared to its average volume of 453,406. The company has a market capitalization of $4.57 billion and a price-to-earnings ratio of 180.69. The business has a 50 day moving average price of $88.95 and a 200 day moving average price of $87.60. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $138.70. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The business had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. The company’s revenue for the quarter was up 83.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.39) earnings per share. On average, analysts forecast that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of BLLN. Perceptive Advisors LLC boosted its stake in Billiontoone by 26.1% during the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after buying an additional 19,000 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Billiontoone by 8,603.4% in the 1st quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after buying an additional 12,561 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Billiontoone by 151.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after buying an additional 18,389 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Billiontoone during the 1st quarter worth about $4,046,000. Finally, Public Employees Retirement System of Ohio bought a new position in shares of Billiontoone during the 1st quarter worth about $1,539,000.

Analyst Ratings Changes

BLLN has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Guggenheim increased their price target on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Weiss Ratings lowered shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, June 5th. BTIG Research cut their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Finally, Wells Fargo & Company reduced their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Billiontoone presently has a consensus rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.